Manufacturer record
Aarti Drugs Limited: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Aarti Drugs Limited (Maharashtra) were declared Not of Standard Quality between January 2019 and January 2019. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Aarti Drugs Limited in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Norfloxacin IP | NFC/18121100Mfg 2018-12 · Exp 2023-11 | Loss on DryingLoss on drying | CDTL MumbaiCDSCO lab | Jan 2019 |
| Norfloxacin IP | NFC/18121099Mfg 2018-12 · Exp 2023-11 | Loss on DryingLoss on drying | CDTL MumbaiCDSCO lab | Jan 2019 |
| Norfloxacin IP | NFC/18121098Mfg 2018-12 · Exp 2023-11 | Loss on DryingLoss on drying | CDTL MumbaiCDSCO lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.